Key facts for NCD 200.2
- Benefit category
- Durable Medical Equipment
- Effective date
- 09/10/2007
- Implemented 01/22/2008
- Transmittal
- Transmittal 79
- Versions published
- 1
TL;DR
NCD 200.2 sets Medicare's national policy for nebulized beta adrenergic agonist therapy for lung diseases under the benefit category "Durable Medical Equipment", effective 09/10/2007 and implemented 01/22/2008. After examining the available medical evidence, the Centers for Medicare & Medicaid Services determines that no national coverage determination is appropriate at this time. Section 1862(a)(1)(A) of the Social Security Act decisions should be made by local… It has been revised once since publication and binds every Medicare Administrative Contractor nationally.
Item or service described
A. General
Lung diseases such as chronic obstructive pulmonary disease (COPD) and asthma are characterized by airflow limitation that may be partially or completely reversible. Pharmacologic treatment with bronchodilators is used to prevent and/or control daily symptoms that may cause disability for persons with these diseases. These medications are intended to improve the movement of air into and from the lungs by relaxing and dilating the bronchial passageways. Beta adrenergic agonists are a commonly prescribed class of bronchodilator drug. They can be administered via nebulizer, metered dose inhaler, orally, or dry powdered inhaler.
Nebulized beta adrenergic agonist with racemic albuterol has been used for many years. More recently, levalbuterol, the (R) enantiomer of racemic albuterol, has been used in some patient populations. There are concerns regarding the appropriate use of nebulized beta adrenergic agonist therapy for lung disease.
Indications and limitations of coverage
B. Nationally Covered Indications
N/A
C. Nationally Non-Covered Indications
N/A
D. Other
After examining the available medical evidence, the Centers for Medicare & Medicaid Services determines that no national coverage determination is appropriate at this time. Section 1862(a)(1)(A) of the Social Security Act decisions should be made by local Medicare Administrative Contractors through a local coverage determination process or case-by-case adjudication. See Heckler v. Ringer, 466 U.S. 602, 617 (1984) (Recognizing that the Secretary has discretion to either establish a generally applicable rule or to allow individual adjudication.). See also, 68 Fed. Reg. 63692, 63693 (November 7, 2003).
Text reproduced from the CMS Medicare Coverage Database record for NCD 200.2 version 1. View the original on cms.gov.
Local policies that build on this NCD
1 active Local Coverage Determination cites NCD 200.2 among its related national policies. An LCD may not conflict with the national determination; read it for the contractor's documentation and coding detail in that jurisdiction.
- LCD L33370: Nebulizers · CGS Administrators, LLC; Noridian Healthcare Solutions, LLC
How MACs bill NCD 200.2
A National Coverage Determination states the policy; the Medicare Administrative Contractors publish the articles that turn it into claim edits. 1 current article in the Medicare Coverage Database names NCD 200.2, 1 of them with a covered ICD-10-CM list, from 2 contractors. The lists can differ by contractor even though the NCD is national, because each MAC codes the policy for its own claims system; check the article of the contractor that processes the claim.
| Contractor | Articles |
|---|---|
| CGS Administrators, LLC | A52466 |
| Noridian Healthcare Solutions, LLC | A52466 |
A52466: Nebulizers - Policy Article
Article, effective 2026-02-01 · CGS Administrators, LLC (17013, 18003); Noridian Healthcare Solutions, LLC (16013, 19003) · CMS record
215 covered ICD-10-CM codes in 16 groups. Local policy: L33370 Nebulizers.
First covered codes: A15.0 Tuberculosis of lung; B20 Human immunodeficiency virus [HIV] disease; B59 Pneumocystosis; E84.0 Cystic fibrosis with pulmonary manifestations; J39.8 Other specified diseases of upper respiratory tract; J47.0 Bronchiectasis with acute lower respiratory infection; …
Coverage analysis history
CMS opens a national coverage analysis (NCA) to create or reconsider an NCD; the analysis carries a CAG tracking number, the evidence review and the decision memo. The Medicare Coverage Database links one analysis to NCD 200.2, listed here in the order CMS opened them (by NCA record number). A reconsideration ("Recon") revisits an earlier decision; an analysis whose status is open is still in progress.
- CAG-00354N Nebulized Beta Adrenergic Agonist Therapy for Lung Diseases (New, Closed)
Revision history
12/2007 - Provided noncoverage policy. Effective date 09/10/2007. ( TN 79 ) (CR5820)
How this NCD shows up on remittances
A service denied under a National Coverage Determination returns CARC 50 (not deemed medically necessary) with remark N386 (decision based on an NCD); a denial citing a local policy instead carries N115. Because NCDs bind nationally, the appeal path is documentation that the patient meets the indications above, not a contractor-policy argument.
For teams evaluating QuickIntell software
Evaluate a coverage-review workflow around NCD 200.2
Explore QuickAuth for requirement checks, documentation preparation and status tracking with staff oversight. Bring the policy-review steps your team repeats to a scoped evaluation, and confirm plan-specific requirements and supported actions. Use QuickRCM to evaluate the separate claim and denial workflow; a published NCD is not an authorization or payment guarantee.
Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.
Frequently asked questions — NCD 200.2
What does NCD 200.2 cover?
After examining the available medical evidence, the Centers for Medicare & Medicaid Services determines that no national coverage determination is appropriate at this time. Section 1862(a)(1)(A) of the Social Security Act decisions should be made by local Medicare Administrative Contractors through a local coverage determination process or case-by-case adjudication. See Heckler v. Ringer, 466 U.S. 602, 617 (1984)… The full indications and limitations are reproduced on this page from the CMS Medicare Coverage Database.
When did NCD 200.2 take effect?
The current version (1) is effective 09/10/2007, implemented 01/22/2008, published in transmittal 79. This is the only published version.
Does a Local Coverage Determination override NCD 200.2?
No. A National Coverage Determination binds all Medicare Administrative Contractors; an LCD can only address services or circumstances the NCD leaves open. Claims denied under this NCD typically return CARC 50 with remark N386 (NCD) rather than N115 (LCD).
Sources
Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.
- Medicare Coverage Database NCDs via the CMS Coverage APIVersion API snapshot 2026-09-27 · effective 2026-09-20 · file national-coverage-ncd.jsonSHA-256 a90fadfd264b9ef4…
- Medicare Coverage Database, current Billing and Coding Articles exportVersion MCD release 2026-11-12 · effective 2026-11-08 · file article.csvSHA-256 b475751458564786…
- Medicare Coverage Database national coverage analyses (NCA/CAL report) via the CMS Coverage APIVersion API snapshot 2026-11-16 · effective 2026-11-16 · file national-coverage-ncacal.jsonSHA-256 563369a07b95140a…
Disclaimer
This page reproduces the CMS National Coverage Determination text and, for laboratory NCDs, the CMS ICD-10 edit lists, as an operational reference. Coverage decisions depend on the full policy, the claim and the contractor; nothing here is legal, clinical or billing advice. CPT codes are shown as numbers only; CPT descriptors are copyright AMA.
Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.